Andrea Forschner

43PUBLICATIONS
150CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyGene and molecular therapyEthical use of new technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Oct 05, 2026
Poliosis predicts durable response to immune-checkpoint blockade in metastatic melanoma: a multicenter cohort study.

|Oct 01, 2026
Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

|Sep 08, 2026
Cancer survivorship in malignant melanoma.

|Sep 07, 2026
Improvement of overall survival in patients with cutaneous melanoma at a tertiary care center in Germany from 2001 to 2020.

|Jul 02, 2026
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years.

|Jul 01, 2026
Perioperative PD-1-inhibition in melanoma patients - a retrospective analysis from eight German skin cancer centers.

Pageof 8

Frequent Collaborators

7 joint publications

Markus Reitmajer

6 joint publications

Christoffer Gebhardt

5 joint publications

Claus Garbe

5 joint publications

Maximilian Haist